12/10/2024
11:15 PM | Chemomab Therapeutics (Filer)
| Form EFFECT | |
12/02/2024
3:22 PM | Chemomab Therapeutics (Filer)
| Form POS AM | |
11/29/2024
2:04 PM | Chemomab Therapeutics (Subject)
Mor George Adi (Filed by)
| Form SC 13D/A | |
11/21/2024
9:59 AM | Chemomab Therapeutics (Subject)
Otto Erik (Filed by)
| Form SC 13G | |
11/18/2024
3:19 PM | Chemomab Therapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/14/2024
6:00 AM | Chemomab Therapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/16/2024
3:34 PM | Chemomab Therapeutics (Subject)
OrbiMed Israel BioFund GP Limited Partnership (Filed by)
| Form SC 13D/A | |
09/12/2024
3:56 PM | Chemomab Therapeutics (Subject)
OrbiMed Israel GP Ltd. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/09/2024
5:16 AM | Chemomab Therapeutics (Filer)
| Form 424B3 | |
09/08/2024
11:15 PM | Chemomab Therapeutics (Filer)
| Form EFFECT | |
08/21/2024
6:00 AM | Chemomab Therapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/20/2024
1:36 PM | Chemomab Therapeutics (Subject)
SPHERA FUNDS MANAGEMENT LTD. (Filed by)
| Form SC 13G | |
08/09/2024
3:39 PM | Chemomab Therapeutics (Filer)
| Form D
Notice of Exempt Offering of Securities | |
07/25/2024
7:09 AM | Chemomab Therapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/09/2024
6:00 AM | Chemomab Therapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/08/2024
6:05 AM | Chemomab Therapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/28/2024
5:03 AM | Chemomab Therapeutics (Filer)
| Form 20-F
Registration statement / Annual report / Transition report | |
03/11/2024
6:19 PM | Chemomab Therapeutics (Subject)
OrbiMed Israel BioFund GP Limited Partnership (Filed by)
| Form SC 13D/A | |
03/07/2024
6:00 AM | Chemomab Therapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/03/2024
6:00 AM | Chemomab Therapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
Free CMMB Stock Alerts